Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients.
- 1 April 1982
- journal article
- clinical trial
- Published by Wiley
- Vol. 13 (4) , 519-522
- https://doi.org/10.1111/j.1365-2125.1982.tb01414.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASISThe Lancet, 1981
- Serum levels of 8-methoxypsoralen: difference between two oral methods of administration*British Journal of Dermatology, 1980
- Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brandsArchives of Dermatological Research, 1980
- Plasma Levels of 8-Methoxypsoralen Determined by High-Pressure Liquid Chromatography in Psoriatic Patients Ingesting Drug from Two ManufacturersJournal of Investigative Dermatology, 1980
- Improved Delivery of MethoxsalenJournal of Pharmaceutical Sciences, 1979
- Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tabletsActa Dermato-Venereologica, 1978
- Pharmacokinetics and metabolite-pattern of 8-methoxypsoralen in man following oral administration as compared to the pharmacokinetics in rat and dogArchives of Dermatological Research, 1978
- Oral Methoxsalen Photochemotherapy for The Treatment of Psoriasis: a Cooperative Clinical TrialJournal of Investigative Dermatology, 1977
- Phototesting and dosimetry for photochemotherapyBritish Journal of Dermatology, 1977
- Difference in the Efficiency of Two Delivery Forms of 8-MethoxypsoralenDermatology, 1976